Eighty percent. That is the number every hospital executive should be losing sleep over.
When someone finishes a body scan at Neko Health, a doctor walks them through the results, then offers next year's appointment before they leave the building. Four in five say yes and pay for it on the spot.
Read that twice. Healthy people. No symptoms. No diagnosis. Prepaying for a medical visit twelve months away.
Healthcare has spent fifty years begging people to care about prevention. Daniel Ek's startup got them to pay for it in advance. And the reason has almost nothing to do with the lasers.
The Technology Is the Least Interesting Part of the Story
The scan itself is genuinely impressive. You walk into a clinic, and in under an hour a mix of thermal cameras, 3D imaging, an ECG, lasers and finger sensors capture millions of data points across your heart, skin and blood. An AI builds the report. A doctor reads it back to you while you are still in the room. The UK scan costs £299.
Here is the part nobody wants to hear. The hardware is not the moat.
Competitors already exist. Prenuvo and Ezra run full-body MRI scans that can cost over $1,000. Better sensors get copied. Cheaper scans get built. If the machine were the whole company, Neko would be a gadget, not a $1.8 billion business.
So what did Ek actually build?
Healthcare Has Never Known How to Make Money From Healthy People
Call it the Well-Patient Problem.
Every incentive in medicine is wired to sickness. Insurers pay when you are ill. Hospitals bill procedures, not prevention. Your doctor, as the clip that kicked this off put it, mostly sees you once something has already gone wrong.
That single fact is why prevention always loses. There has never been a clean way to turn a healthy person into recurring revenue. So the whole system waits.
The irony is that everyone agrees this is backwards. Governments and health systems worldwide are now pushing hard toward preventative care, partly to offset the soaring cost of chronic disease in ageing populations. The will is there. The business model never was.
There are fair critics, too. Some doctors warn that scanning healthy people risks overdiagnosis and the anxiety of chasing findings that were never going to hurt anyone. That debate is real and worth having. But notice it is a debate about the medicine, not the model. The model works regardless.
Neko did not invent prevention. It invented a way to get paid for it.
Ek Didn't Copy Apple. He Copied Spotify.
Ek likes to compare Neko to Apple, pointing to vertical integration and owning the full stack. That is the engineer's answer.
The marketer's answer is simpler. He ran the Spotify playbook.
Spotify's real genius was never the music. It was turning a one-off purchase into a recurring relationship you forget to question. Neko makes the same move at the perfect moment. The scan ends, your results are fresh, your attention is total, and that is exactly when they ask you to rebook.
Eighty percent say yes. A one-time checkup quietly becomes a subscription.
Ek put it plainly: “We’re not selling a product, we’re selling an experience.”
That sentence is the whole strategy. Nobody prepays for a product. People prepay for a relationship with their own future self.
Your Moat Is Almost Never the Thing You Think It Is
If you are building anything in healthtech, here is the uncomfortable part.
You are probably in love with your technology. Your diagnostic. Your model. Your device. And your technology is almost certainly not your moat.
Neko's edge is not the scanner. It is the renewal rate and a waitlist of more than 100,000 people. Recurring revenue is what got valued at $1.8 billion, not the thermal cameras.
So the real question is not whether your tech is good enough. The question is this: at what exact moment do you ask for the money, and does your model make the customer say yes again next year?
If you are still selling one-off, you are leaving the entire company on the table.
The Best Technology in the World Still Loses to a Better Model
There is something very human underneath all of this. People do not fear scans. They fear finding out too late. Neko sells the opposite of that fear, and it sells it as a habit instead of a panic.
That is why this is Ek's second billion-dollar company, and why it probably will not be his last.
The lesson is not build a body scanner.
The lesson is that Ek did not out-engineer healthcare. He out-priced its assumptions.
If prevention finally has a working business model, who gets disrupted first: hospitals, insurers, or the annual physical itself?
Drop your take in the comments. I read every one.